Stephen Long served as a top administrator at the National Institutes of Health
Stephen W. Long
Stephen W. Long has been named associate director for administration of the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore, Md. In this newly created position, he will oversee the cancer center’s research activities.
Long comes to the University of Maryland Medical Center from the National Institutes of Health, where he was associate director for administration and executive officer of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) since 1999. There, he oversaw facilities, administration, ethics, contracts, human resources and financial management for research programs.
Previously, Long served as director of the NIAAA Office of Policy, Legislation and Public Liaison and director of the Planning and Financial Management Branch at the institute. He also was director of financial management for the Alcohol, Drug Abuse and Mental Health Administration and a budget analyst in the Department of Health and Human Services.
“Steve has a long and distinguished career in health services and research management at the federal level. We are most fortunate to have someone of his background and experience assume this critical position overseeing the research mission of our cancer center,” says Kevin J. Cullen, M.D., director of the University of Maryland Marlene and Stewart Greenebaum Cancer Center and a professor of medicine at the University of Maryland School of Medicine.
During his tenure at the NIAAA, Long received more than a dozen service and achievement awards. A graduate of the University of Rhode Island, he lives with his family in Bethesda.
“The University of Maryland Greenebaum Cancer Center is recognized for its active translational research program, and I look forward to working with a very talented team of scientists and clinical investigators to bring discoveries out of the laboratory into the clinic for the benefit of patients,” Long says. He assumed his new position on September 4.
The cancer center is recognized for its multidisciplinary approach to cancer care, with teams of specialists who work together to evaluate and treat patients, as well as its basic and clinical research programs. Research takes place within five broad disease and basic research program areas – experimental therapeutics, hormone responsive cancers, molecular and structural biology, tumor immunology and immunotherapy and viral oncology.